• Explore /
  • Poster
  • / Using quantitative sensory testing as an early predictor of chronic oxaliplatin neuropathy in gastrointestinal cancer patients.

Using quantitative sensory testing as an early predictor of chronic oxaliplatin neuropathy in gastrointestinal cancer patients.

Abstract Poster

Authors

null

Sangeetha Meda Reddy

Northwestern University, Feinberg School of Medicine, Chicago, IL

Sangeetha Meda Reddy , Nancy Kwon , Irene B. Helenowski , Robert Norm Harden , Judith A. Paice , Halla Sayed Nimeiri , Mary Frances Mulcahy , Al B. Benson III, Maxwell Thomas Vergo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3540)

DOI

10.1200/jco.2013.31.15_suppl.3540

Abstract #

3540

Poster Bd #

1F

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance).

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance).

First Author: Deirdre R. Pachman

First Author: Lin Shen

First Author: Gong-Rang Chen

First Author: Yongkang Xu